Mithrl has announced a $20 million Series A, led by Obvious Ventures, with participation from Headline, AGI House, and several pharmaceutical executives. The announcement brings up an increasingly important challenge in...read more
Category - Industry trends
The Dangerous Bet Behind Big Pharma’s Silence
Why dismantling America’s biomedical innovation engine is a long-term threat to the very industry staying quiet about it. A recent piece by Steven Usdain, which was also highlighted by Holden Thorp, got me thinking: are...read more
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences I’ve been spending some time thinking on how Voice of the Customer (VoC) programs are evolving as artificial intelligence (AI) becomes...read more
Inside the Biology of 116 Years of Life: What Multiomics Reveals About Extreme Longevity
At enlightenbio, we are deeply committed to studying longevity and health span, which aligns with our personal and professional interests in biological science. For more on this, please see a couple of earlier...read more
